zantac 150, tabletten 150 mg
glaxosmithkline b.v. - ranitidinehydrochloride samenstelling overeenkomend met ; ; ranitidine - filmomhulde tablet - cellulose, microkristallijn (e 460) ; glyceroltriacetaat (e 1518) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; titaandioxide (e 171), - ranitidine
zantac 150 mg/10 ml, drank
medcor pharmaceuticals b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - drank - ranitidine
zantac 150 mg/10 ml, drank
euro registratie collectief b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - drank - ranitidine
zantac 300, tabletten 300 mg
glaxosmithkline b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - filmomhulde tablet - ranitidine
zantac 75 bruis, bruistabletten 75 mg
omega pharma nederland b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - bruistablet - ranitidine
zantac, drank 150 mg/10 ml
glaxosmithkline b.v. - ranitidinehydrochloride samenstelling overeenkomend met; ranitidine; - drank - ranitidine
zantac 50 mg/2 ml inj. opl. i.v./i.m. amp.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 28 mg/ml - eq. ranitidine 25 mg/ml - oplossing voor injectie - 50 mg/2 ml - ranitidinehydrochloride 28 mg/ml - ranitidine
zantac 150 mg/10 ml siroop
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 16,8 mg/ml - eq. ranitidine 15 mg/ml - siroop - 150 mg/10 ml - ranitidinehydrochloride 16.8 mg/ml - ranitidine
zantac 150 mg filmomh. tabl.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 168 mg - eq. ranitidine 150 mg - filmomhulde tablet - 150 mg - ranitidinehydrochloride 168 mg - ranitidine
zantac 150 mg bruistabl.
glaxosmithkline pharmaceuticals sa-nv - ranitidinehydrochloride 168 mg - eq. ranitidine 150 mg - bruistablet - 150 mg - ranitidinehydrochloride 168 mg - ranitidine